Skip to content
Open access · CC-BY via OpenAlex

Cirrhosis-induced oxidative stress in erythrocytes: The therapeutic potential of taurine

Hossein Niknahad, Pooria Sayar Mehrabani, Abdollah Arjmand, Sepideh Alidaee, Sahra Mazloomi, Parinaz Ahmadi, Narges Abdoli, Mohsen Saeed, Mohammad Rezaei, Mohammad Mehdi Ommati, Reza Heidari

Clinical and Experimental Hepatology · 2023 · ▲ 10 citations

Abstract

Aim of the study: Cholestasis/cirrhosis could induce erythrocyte lysis. The incidence of various types of anemia in cirrhosis is approx. 75%. Several studies have mentioned the pivotal role of oxidative stress in this complication. Taurine (TAU) is the human body's most abundant free amino acid. TAU is known as a robust cell membrane stabilizer. Many studies have mentioned that TAU could counteract oxidative stress in various experimental models. The current study was intended to evaluate the effect of TAU on erythrocytes in cirrhotic rats. Material and methods: Bile duct ligation (BDL) surgery was carried out on rats. Then, complete blood count (CBC), hemoglobin (Hgb), hematocrit (HTC), and erythrocytes' G6PD, catalase (CAT), and superoxide dismutase (SOD) activity were measured. Moreover, biomarkers of oxidative stress were assessed, and the erythrocytes' morphological changes were monitored in the cirrhotic mice exposed to TAU (0.25%, 0.5%, and 1% w : v in drinking water). Results: Significant changes in the assessed erythrocyte parameters (G6PD activity, Hgb, HTC, and erythrocyte count) and red blood cells (RBC) morphological alterations were detected on day 42 after BDL surgery. Biomarkers of oxidative stress also did not change at the time points, except on post-BDL days 28 and 42. A significant decrease in blood parameters was evident at post-BDL day 42. All doses of TAU (0.25%, 0.5%, and 1% w : v in drinking water) significantly improved erythrocyte parameters and encountered oxidative stress in the erythrocytes of cirrhotic animals. Conclusions: These data indicate that TAU could be a safe agent to mitigate cirrhosis-induced erythrocyte damage and anemia. Further investigations are necessary to prove this in clinical settings.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.5114/ceh.2023.126028
Canonical
link ↗
Fetched
2026-11-09 MST

Cite this

APA
Niknahad, H., Mehrabani, P.S., Arjmand, A., Alidaee, S., Mazloomi, S., Ahmadi, P., Abdoli, N., Saeed, M., Rezaei, M., Ommati, M.M., &amp; Heidari, R. (2023). Cirrhosis-induced oxidative stress in erythrocytes: The therapeutic potential of taurine. <em>Clinical and Experimental Hepatology</em>. https://doi.org/10.5114/ceh.2023.126028
Vancouver
Niknahad H, Mehrabani PS, Arjmand A, Alidaee S, Mazloomi S, Ahmadi P, et al. Cirrhosis-induced oxidative stress in erythrocytes: The therapeutic potential of taurine. Clinical and Experimental Hepatology. 2023. doi:10.5114/ceh.2023.126028.
BibTeX
@article{hossein2023Cirrho, title = {Cirrhosis-induced oxidative stress in erythrocytes: The therapeutic potential of taurine}, author = {Hossein Niknahad and Pooria Sayar Mehrabani and Abdollah Arjmand and Sepideh Alidaee and Sahra Mazloomi and Parinaz Ahmadi and Narges Abdoli and Mohsen Saeed and Mohammad Rezaei and Mohammad Mehdi Ommati and Reza Heidari}, journal = {Clinical and Experimental Hepatology}, year = {2023}, doi = {10.5114/ceh.2023.126028}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings